Niederberger C, Pellicer A, Cohen J, Gardner DK, Palermo GD, O’Neill CL, et al. Forty years of IVF. Fertil Steril. 2018;110:185–324.e5.
Kübler K, Klingmüller D, Gembruch U, Merz WM. High-risk pregnancy management in women with hypopituitarism. J Perinatol. 2009;29:89–95.
Aulinas A, Stantonyonge N, García-Patterson A, Adelantado JM, Medina C, Espinós JJ, et al. Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome. Pituitary. 2022;25:275–84.
Vila G, Fleseriu M. Fertility and pregnancy in women with hypopituitarism: A systematic literature review. J Clin Endocrinol Metab. 2020;105:e53–65.
Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril. 2018;109:708–19.e8.
Hall R, Manski-Nankervis J, Goni N, Davies MC, Conway GS. Fertility outcomes in women with hypopituitarism. Clin Endocrinol (Oxf). 2006;65:71–4.
Article CAS PubMed Google Scholar
Sonntag B, Nawroth F, Ludwig M, Bullmann C. Anti-Müllerian hormone in women with hypopituitarism diagnosed before or during adolescence. Reprod Biomed Online. 2012;25:190–2.
Article CAS PubMed Google Scholar
Correa FA, Bianchi PHM, Franca MM, Otto AP, Rodrigues RJM, Ejzenberg D, et al. Successful pregnancies after adequate hormonal replacement in patients with combined pituitary hormone deficiencies. J Endocr Soc. 2017;1:1322–30.
Article PubMed PubMed Central Google Scholar
Tsilchorozidou T, Conway GS. Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clin Endocrinol (Oxf). 2004;61:567–72.
Kim HJ, Lee D-Y, Yoon B-K, Choi D. Uterine development after estrogen replacement therapy in women with different etiologies of primary hypogonadism. J Pediatr Adolesc Gynecol. 2016;29:344–7.
Sowithayasakul P, Boekhoff S, Bison B, Müller HL. Pregnancies after childhood craniopharyngioma: Results of KRANIOPHARYNGEOM 2000/2007 and review of the literature. Neuroendocrinology. 2020;111:16–26.
Overton CE, Davis CJ, West C, Davies MC, Conway GS. High risk pregnancies in hypopituitary women. Hum Reprod. 2002;17:1464–7.
Shinar S, Many A, Maslovitz S. Questioning the role of pituitary oxytocin in parturition: spontaneous onset of labor in women with panhypopituitarism – a case series. Eur J Obstet Gynecol Reprod Biol. 2016;197:83–5.
Article CAS PubMed Google Scholar
Yasmin E, Davies M, Conway G, Balen AH. British fertility society: ‘Ovulation induction in WHO Type 1 anovulation: Guidelines for practice’ produced on behalf of the BFS policy and practice committee. Hum Fertil. 2013;16:228–34.
Pandurangi M, Tamizharasi M, Reddy NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci. 2015;8:146.
Yildirim G, Ficicioglu C, Attar R, Akcin O, Tecellioglu N. Comparision of reproductive outcome of the women with hypogonadotropic hypogonadism and tubal factor infertility. Clin Exp Obstet Gynecol. 2010;37(2):120-2.
Ghaffari F, Arabipoor A, Lankarani NB, Etminan Z, Tehraninejad ES. Assisted reproductive technique outcomes in hypogonadotropic hypogonadism women. Ann Saudi Med. 2013;33:235–40.
Article PubMed PubMed Central Google Scholar
Weiss NS, Nahuis M, Bayram N, Mol BWJ, Van der Veen F, van Wely M. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Cochrane Database Syst Rev. 2015;CD010290.
Yen & Jaffe’s Reproductive Endocrinology - 9780323810074 [Internet]. US Elsevier Health. [cited 2023 Aug 8]. Available from https://www.us.elsevierhealth.com/yen-jaffes-reproductive-endocrinology-9780323810074.html.
European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab. 2001;86:2607–18.
Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril. 1991;56:1048–53.
Article CAS PubMed Google Scholar
White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab. 1996;81:3821–4.
Salle A, Klein M, Pascal-Vigneron V, Dousset B, Leclere J, Weryha G. Successful pregnancy and birth after sequential cotreatment with growth hormone and gonadotropins in a woman with panhypopituitarism: a new treatment protocol. Fertil Steril. 2000;74:1248–50.
Article CAS PubMed Google Scholar
van Santbrink EJ, Donderwinkel PF, van Dessel TJ, Fauser BC. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. Hum Reprod Oxf Engl. 1995;10:1048–53.
Green KA, Zolton JR, Schermerhorn SMV, Lewis TD, Healy MW, Terry N, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertil Steril. 2017;107:924–33.e5.
van Zundert SKM, Krol CG, Spaan JJ. Management of panhypopituitarism during pregnancy: A case report. Case Rep Womens Health. 2021;32:e00351.
Sekhon L, Feuerstein J, Pan S, Overbey J, Lee JA, Briton-Jones C, et al. Endometrial preparation before the transfer of single, vitrified-warmed, euploid blastocysts: does the duration of estradiol treatment influence clinical outcome? Fertil Steril. 2019;111:1177–85.e3.
Li X, Shi W, Gao Y, Shi J, Li N, Bai H. Is duration of estrogen supplementation associated with clinical outcomes in frozen-thawed autologous single-blastocyst transfer cycles? J Assist Reprod Genet. 2022;39:1087–94.
Article PubMed PubMed Central Google Scholar
Harvey S. Extrapituitary growth hormone. Endocrine. 2010;38:335–59.
Article CAS PubMed Google Scholar
Barreca A, Artini PG, Del Monte P, Ponzani P, Cariola G, Volpe A, et al. In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab. 1993;77:61–7.
Foster CM, Hashimoto N, Randolph JF, Beitins IZ. Comparison of growth hormone and insulin-like growth factor-i regulation of estradiol and progesterone production in human luteinized granulosa cells. Pediatr Res. 1995;38:763–7.
Article CAS PubMed Google Scholar
Kobayashi J, Mizunuma H, Kikuchi N, Liu X, Andoh K, Abe Y, et al. Morphological assessment of the effect of growth hormone on preantral follicles from 11-day-old mice in an in vitro culture system. Biochem Biophys Res Commun. 2000;268:36–41.
Article CAS PubMed Google Scholar
de Boer JA, van der Meer M, van der Veen EA, Schoemaker J. Growth hormone (GH) substitution in hypogonadotropic, GH-deficient women decreases the follicle-stimulating hormone threshold for monofollicular growth. J Clin Endocrinol Metab. 1999;84:590–5.
Eisenhauer KM, Chun S-Y, Billig H, Hsueh AJW. Growth hormone suppression of apoptosis in preovulatory rat follicles and partial neutralization by insulin-like growth factor binding protein1. Biol Reprod. 1995;53:13–20.
Article CAS PubMed Google Scholar
Mendoza C. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002;17:1017–22.
Article CAS PubMed Google Scholar
Altmäe S, Mendoza-Tesarik R, Mendoza C, Mendoza N, Cucinelli F, Tesarik J. Effect of growth hormone on uterine receptivity in women with repeated implantation failure in an oocyte donation program: A randomized controlled trial. J Endocr Soc. 2018;2:96–105.
Bavan B, Gardner RM, Zhang WY, Aghajanova L. The effect of human growth hormone on endometrial growth in controlled ovarian hyperstimulation cycles. J Pers Med. 2022;12:1991.
Hart RJ. Use of growth hormone in the IVF treatment of women with poor ovarian reserve. Front Endocrinol. 2019;10:500.
De Boer JAM, Schoemaker J, Van Der Veen EA. Impaired reproductive function in women treated for growth hormone deficiency during childhood. Clin Endocrinol (Oxf). 1997;46:681–9.
Menashe Y, Sack J, Mashiach S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum Reprod. 1991;6:670–1.
Article CAS PubMed Google Scholar
Curran A, Peacey S, Shalet S. Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol. 1998;54–8.
Lacroix MC, Guibourdenche J, Frendo JL, Muller F, Evain-Brion D. Human placental growth hormone—a review. Placenta. 2002;23:S87–94.
Giampietro A, Milardi D, Bianchi A, Fusco A, Cimino V, Valle D, et al. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature. Fertil Steril. 2009;91:930.e7–930.e11.
Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:3888–921.
Article CAS PubMed Google Scholar
Wirén L, Boguszewski CL, Johannsson G. Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy. Clin Endocrinol (Oxf). 2002;57:235–9.
Müller J, Starup J, Christiansen JS, Jøgensen JO, Juul A, Skakkebaek NE. Growth hormone treatment during pregnancy in a growth hormone-deficient woman. Eur J Endocrinol. 1995;132:727–9.
Vila G, Akerblad A-C, Mattsson AF, Riedl M, Webb SM, Hána V, et al. Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril. 2015;104:1210-1217.e1.
Article CAS PubMed Google Scholar
Biller BMK, Höybye C, Carroll P, Gordon MB, Birkegård AC, Kelepouris N, et al. Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program. Pituitary. 2021;24:611–21.
Article CAS PubMed PubMed Central Google Scholar
Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210:96–106.
Article CAS PubMed Google Scholar
Ormandy CJ. Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res. 2003;58:297–323.
留言 (0)